Cornell studies find hybrid wine grapes could cut disease pressure in New York vineyards

Cornell-affiliated researchers studying disease-resistant wine grapes in New York say newer hybrid varieties could help growers reduce some disease pressure, but they are not a simple replacement for traditional vines and still need to be judged by region, weather risk and wine quality.

The findings were released Sunday by the New York Wine & Grape Foundation as part of reports on research projects it funded during the 2025-26 cycle. The work drew on two studies, one led by Hans Walter-Peterson of the Finger Lakes Grape Program and another by Alice Wise, a viticulturist with Cornell Cooperative Extension in Suffolk County on Long Island.

The reports come as growers face pressure to limit chemical inputs, manage higher costs and respond to more variable weather. For wineries and the broader beverage sector, the research could shape decisions on whether to replant vineyards, adjust spray programs and market wines tied to sustainability, while also underscoring that disease resistance does not mean a vine is immune.

According to the foundation, interest in disease-resistant cultivars has been rising as more varieties become available for New York conditions. Replanting, however, is expensive and can leave growers waiting years for a commercial crop. That makes field data on disease performance, fruit quality and regional fit especially important before a vineyard owner removes existing vines.

One variety that drew attention in the reports was Aravelle, a Cornell-developed cross of Cayuga White and Riesling. Walter-Peterson said Aravelle appears less prone to bunch rot than Riesling, one of its parent grapes. He also said that in sensory work comparing late-harvested fruit with higher sugar levels, Aravelle rated similarly to Riesling for fruitiness, aromatic intensity and perceived sweetness.

Wise said growers have responded well to Aravelle’s wine, though she cautioned that the variety still presents vineyard challenges. She also pointed to other hybrids she views favorably, including two Sauvignon Blanc hybrids and a Cabernet Sauvignon hybrid, while stressing that disease resistance and vineyard performance vary widely from one hybrid to another.

That regional variation is central to both studies. Wise said a hybrid that performs well on Long Island should not be assumed to perform the same way in the Finger Lakes. Walter-Peterson made the same point in discussing grapes developed in other breeding programs, including Marquette and Itasca from the University of Minnesota. He said those varieties were bred with cold tolerance as a major priority and remain relatively hardy in New York, but they also show traits that have made some growers hesitant to adopt them more widely.

Among those concerns is timing. Walter-Peterson said both Marquette and Itasca tend to emerge from dormancy earlier than most cultivars his team has worked with, which can leave them more exposed to spring frost. In a state where late cold snaps can sharply reduce yields, that kind of risk can offset some of the value of disease resistance.

The researchers also warned against treating hybrids as a cure-all. Wise said hybrids remain susceptible to diseases such as black rot and phomopsis cane and leaf spot. Walter-Peterson said he does not tell growers that any variety can fully eliminate the need for pesticides because disease pressure in New York is too high. He added that depending on the genetics behind resistance, pathogens may eventually adapt in ways that reduce that protection.

Wise said biological pesticides are likely to have a larger role in the future, but she added that more local work is needed to understand how best to use them. She also said viticulture is likely to rely more on digital tools, including artificial intelligence, drones and robotics, as growers try to manage vineyards more precisely.

The reports reflect a broader effort by the New York Wine & Grape Foundation to support applied research for the state’s wine industry. The foundation said it typically spends between $350,000 and $500,000 a year on research and works regularly with Cornell AgriTech in Geneva and the Cornell Lake Erie Research and Extension Laboratory in Portland.

Even with the agronomic promise of hybrids, the commercial outcome will depend on winemakers as much as on plant breeders. Wise said many Long Island winemakers have so far used small-scale “carboy wines” to test fruit from hybrids, which she described as useful but limited in showing the full quality potential of the wines. She said she hopes more producers begin using hybrids in premium bottlings.

That could matter for more than product development. If growers can replace some higher-spray vinifera plantings with varieties that hold up better against certain diseases, wineries may have more room to lower input costs and strengthen sustainability claims. At the same time, the Cornell researchers’ warning about frost, regional fit and continuing spray needs suggests those decisions will require careful site-by-site analysis rather than a broad shift away from established grapes.

Walter-Peterson said consumers who want to support more sustainable farming should ask how disease-resistant grapevines fit into a winery’s lineup and buy those wines when available. The foundation said additional reports and webinars on its funded research are expected to follow.